University of South Florida neuroscientist Brian Giunta, MD, reported the findings May 1 at Experimental Biology 2007 in Washington, DC. His presentation was part of the scientific program of the American Society for Pharmacology and Experimental Therapeutics. The study was conducted using a new mouse model for HIV-related dementia developed by Dr. Giunta and Jun Tan, MD, PhD, director of the Neuroimmunology Laboratory at the Silver Child Development Center, USF Department of Psychiatry,
"These findings suggest that EGCG, the green tea-derived compound, may represent a new and natural compound for the prevention and treatment of this devastating disease," Dr. Giunta said.
"This is a very important finding in the prevention and treatment of HIV-related dementia, which is usually observed in the late stages of HIV disease," said Abdul S. Rao, MD, MA, DPhil, senior associate vice president for USF Health and vice dean for research and graduate affairs at the College of Medicine. "The neuroprotective effects of EGCG, the green-tea extract, may offer an alternative to existing mono or combination antiretroviral therapies that are known to have poor central nervous system penetration."
HIV-associated dementia, a debilitating cognitive, emotional, and physical disorder, affects 22 percent of HIV-infected adults and more than half of HIV-infected children. Symptoms often begin with slight changes in behavior, intellectual ability, memory, and muscle coordination. Some patients experience depression-like symptoms such as loss of appetite and motivation. Tasks requiring complex thinking and high concentration become difficult, and motor skills gradually deteriorate over time.
The highly active antiretroviral therapies used in developed nations appear to slow the development of brain damage in patients with HIV-related dementia, making it a protracted disorder rather than an acute one. Unfortunately, these therapies neither cure nor prevent development of HIV-associated dementia and several epidemiologic studies indicate they increase the prevalence of the dementia. Currently, no treatments specifically target this neuropsychiatric disorder.
HIV-associated dementia is believed to be caused by the direct effects of HIV upon the brain. The virus secretes proteins known as Tat and gp120, which have direct toxic effects on the neurons. The proteins also have indirect effects caused by the release of chemical messengers known as cytokines, which interact with the HIV proteins to cause death of the brain cells. High levels of these cytokines alone also are toxic to the brain.
When healthy mice were given doses of the HIV proteins Gp120 and/or Tat, in combination with a cytokine known as interferon-gamma, they developed brain damage closely resembling that seen in HIV-associated dementia in humans. Dr. Giunta said the finding may help explain the cognitive and behavioral changes in individuals infected with HIV.
Dr. Giunta then used epigallocatechin-3-gallate (EGCG), the major antioxidant derived from green tea, to break into this pathway of neurotoxicity. He was successful both in cell studies and in studies involving the new mouse model of the disease.
Cultured neurons from mice were exposed to EGCG before being given a cocktail of the two neurotoxic HIV proteins and the toxic cytokine. The green tea compound inhibited the ability of the cytokine to act with the HIV proteins to cause death and damage of the neurons. In further confirmation, the green tea compound also inhibited the neurotoxic properties of these HIV proteins in the presence of the cytokine in live mice.
Anne DeLotto Baier | EurekAlert!
Building a brain, cell by cell: Researchers make a mini neuron network (of two)
23.05.2018 | Institute of Industrial Science, The University of Tokyo
Research reveals how order first appears in liquid crystals
23.05.2018 | Brown University
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
23.05.2018 | Life Sciences
23.05.2018 | Life Sciences
23.05.2018 | Physics and Astronomy